Late treatment study
, study not available yet (News) (not included in the study count)
NIH halts clinical trial of hydroxych loroquine
NIH halts late stage trial reporting no harm and no benefit. 470 patients.
Currently no formal study is available so this is not included in the study count.
Please send us corrections, updates, or comments.